Related Experiment Video
Updated: Mar 30, 2026

07:32
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
2.1K
Update on Mastocytosis (Part 1): Pathophysiology, Clinical Features, and Diagnosis
J M Azaña1, A Torrelo2, A Matito3
1Servicio de Dermatología, Complejo Hospitalario Universitario, Albacete, España.
Actas Dermo-Sifiliograficas
|November 8, 2015
Summary
Mastocytosis involves abnormal mast cell growth, often affecting the skin. Recent research highlights the role of c-kit mutations in its development and diagnosis.
Area of Science:
- Hematology
- Dermatology
- Genetics
Background:
- Mastocytosis is a rare disorder of clonal mast cell proliferation affecting various organs, primarily the skin.
- It impacts both sexes equally and can manifest at any age, commonly in early childhood or adulthood.
- Recent advancements have improved understanding of mastocytosis pathophysiology.
Purpose of the Study:
- To summarize the current understanding of mastocytosis, including its pathophysiology and clinical presentation.
- To emphasize the diagnostic significance of skin lesions in mastocytosis.
- To highlight the role of genetic mutations in mast cell disorders.
Main Methods:
- Review of current literature on mastocytosis.
- Analysis of the role of somatic c-kit mutations.
- Examination of immunophenotypic features in mast cell disorders.
Main Results:
- Mastocytosis is characterized by clonal mast cell proliferation with diverse clinical manifestations.
- Skin lesions are a key diagnostic indicator for most patients.
- Somatic c-kit mutations and aberrant immunophenotypic features are crucial in mastocytosis pathophysiology.
Conclusions:
- Mastocytosis is a complex group of disorders with significant implications for skin health.
- Understanding genetic factors like c-kit mutations is vital for diagnosis and management.
- Skin manifestations are central to identifying and diagnosing mastocytosis.
Related Concept Videos
Toxidromes: Clinical Features
124
Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
124
Cardiomyopathy III: Hypertrophic Cardiomyopathy
708
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
708
Myocarditis II: Clinical Features and Diagnostic Tests
445
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
445
Cystic Fibrosis: Pathogenesis
1.1K
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
Metastasis
6.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Smooth Endoplasmic Reticulum
8.8K
Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
8.8K

